The BET protein inhibitor apabetalone (RVX-208) prevents doxorubicin-induced endothelial senescence

Back

ESC Professional Premium Access

The BET protein inhibitor apabetalone (RVX-208) prevents doxorubicin-induced endothelial senescence

Session: Novel insights into ageing and senescence

Topic: Stem Cells, Cell Cycle, Cell Senescence, Cell Death

Speaker: Doctor S. Mohammed (Zurich, CH)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Shafeeq Ahmed Mohammed

University Hospital Zurich, Zurich (Switzerland)

2 followers

8 more presentations in this session

The effect of CD38 inhibition in age-associated vascular dysfunction

Speaker: Doctor Y. Puspitasari (Schlieren, CH)

The role of cellular senescence in aortic dissection

Speaker: Doctor E. Nakao (Kurume, JP)

Non-cell-autonomous effects of arginase-II in macrophages on cardiomyocytes in aging

Speaker: Doctor D. Potenza (Fribourg, CH)

Sirt5 as a mediator of endothelial and vascular dysfunction: potential therapeutic target in aging-related vascular diseases

Speaker: Doctor K. Yang (Zurich, CH)

Digoxin reduces senescence and restores dysfunctional endothelial-subcutaneous adipocyte cross-talk and dysregulated glucose homeostasis in patients with type 2 diabetes mellitus

Speaker: Doctor O. Brown (Leeds, GB)

Access the full session

Novel insights into ageing and senescence

Speakers: Doctor S. Mohammed, Doctor Y. Puspitasari, Doctor E. Nakao, Doctor D. Potenza, Doctor K. Yang...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources